The Japanese government granted fast-track approval to COVID-19 vaccines developed by Moderna Inc. of the United States and Britain's AstraZeneca Plc on Friday, taking a major step toward speeding up its sluggish inoculation drive.The health ministry said it confirmed both to be safe and effective, bringing the number of available vaccines in the country to three, including one developed by U.S. pharmaceutical company Pfizer Inc. and its German partner BioNTech SE already in use.The Moderna vaccine, greenlit for use in people aged 18 or older, is slated to be administered at mass vaccinatio…READ FULL ARTICLE
